glucovance-250-mg-1-25-mg-fc-tab
Glucovance 250 mg/1.25 mg FC tab (250/1.25 mg)
                                            Manufacturer:
                                            
Merck 
                                        
                                    
                                            Distributor:
                                            
Zuellig 
                                        
                                    
                                            Contents:
                                            
glibenclamide, metformin hydrochloride                                        
                                    
                                            MIMS Class:
                                            Antidiabetic Agents     
                                        
                                    
                                            Form:
                                            Tablet
                                        
                                    
                                            Color:
                                            
Yellow                                        
                                    
                                            Size:
1.31 cm                                        
                                    
                                            Shape:
                                            Oblong
                                        
                                    
                                            Markings1:
                                            250
                                        
                                    
                                            Markings2:
                                            1.25
                                        
                                    
                Advertisement
        
    
                Advertisement
        
    
                Advertisement
        
    
                Advertisement
        
    
                Advertisement
        
    
                Advertisement
        
     
 
            
 
         
                 
                                     
                             
                                             
                                             Sign Out
 Sign Out
                                     
                                             
                                             
                                            